World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
50
Citations
9535
World Ranking
4240
National Ranking
1931

Best Publications

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance.

    Vivek Verma;Vivek Verma;Rajeev K Shrimali;Rajeev K Shrimali;Shamim Ahmad;Winjie Dai

  • Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study

    Dmitriy Zamarin;Robert A. Burger;Michael W. Sill;Daniel J. Powell

  • Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?

    Sandra Demaria;Chandan Guha;Jonathan Schoenfeld;Zachary Morris

  • Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.

    Sacha Gnjatic;Vincenzo Bronte;Laura Rosa Brunet;Marcus O. Butler

  • Future perspectives in melanoma research

    Paolo A. Ascierto;Sanjiv Agarwala;Gerardo Botti;Alessandra Cesano

  • Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation

    Unknown

  • Defining the critical hurdles in cancer immunotherapy

    Bernard A. Fox;Bernard A. Fox;Dolores J. Schendel;Lisa H. Butterfield;Steinar Aamdal

  • Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors

    Asha Nayak-Kapoor;Zhonglin Hao;Ramses Sadek;Robin Dobbins

  • A phase I vaccine trial with peptides reflecting ras oncogene mutations of solid tumors.

    S N Khleif;S I Abrams;J M Hamilton;E Bergmann-Leitner

  • MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects.

    Vivek Verma;Vivek Verma;Nazli Jafarzadeh;Shannon Boi;Subhadip Kundu

  • Mutant KRAS conversion of conventional T cells into regulatory T cells

    Stephanie Zdanov;Magis Mandapathil;Rasha Abu Eid;Saudat Adamson-Fadeyi

  • Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis

    Rajeev Kumar Shrimali;Shamim Ahmad;Vivek Verma;Peng Zeng

  • Selective inhibition of regulatory T cells by targeting the PI3K-Akt pathway.

    Rasha Abu-Eid;Raed N. Samara;Laurent Ozbun;Maher Y. Abdalla

  • A phase 1 study of MEDI4736, an anti–PD-L1 antibody, in patients with advanced solid tumors.

    Jose Lutzky;Scott Joseph Antonia;Andy Blake-Haskins;Xia Li

  • Anti‐PD‐1 synergizes with cyclophosphamide to induce potent anti‐tumor vaccine effects through novel mechanisms

    Unknown

  • Clinical trial designs for the early clinical development of therapeutic cancer vaccines

    Richard M. Simon;Seth M. Steinberg;Michael Hamilton;Allan Hildesheim

  • Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers.

    Antoun Toubaji;Moujahed Achtar;Maurizio Provenzano;Vincent E. Herrin

  • Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)

    Alessandro D. Santin;Wei Deng;Michael Frumovitz;Natalia Buza

  • A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

    Osama E. Rahma;Ed Ashtar;Malgorzata Czystowska;Marta E. Szajnik

Frequent Co-Authors

Jay A. Berzofsky
Jay A. Berzofsky National Institutes of Health
Paolo A. Ascierto
Paolo A. Ascierto National Institutes of Health
Silvia C. Formenti
Silvia C. Formenti Cornell University
Dong-Wan Kim
Dong-Wan Kim Seoul National University Hospital
Kunle Odunsi
Kunle Odunsi Roswell Park Cancer Institute
Michael J. Birrer
Michael J. Birrer University of Arkansas for Medical Sciences
Lisa H. Butterfield
Lisa H. Butterfield University of California, San Francisco
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Sandra Demaria
Sandra Demaria Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Samir N. Khleif

Recently Published Articles